Get 40% Off
☕ Buy the dip? After losing 17%, Starbucks sees an estimated 20% upside. See the top Undervalued stocks!Unlock list

4 Stocks To Watch: COLL, JUNO, NKTR, NTNX

Published 11/15/2017, 11:41 PM
Updated 07/09/2023, 06:31 AM

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) had a follow-through on Wednesday, running all the way up to 15.85 from 9.25, before pulling back and closing up 98 cents, or 7%, to 15.14, on 1.22 million shares traded. This has been a big move with a breakout. I’m really looking forward to some backing and filling, and consolidation, because I think it’s going to 17, and then 20 1/2-21. It has 22.4 days to cover .

Juno Therapeutics, Inc. (NASDAQ:JUNO) is looking good. It had a major, explosive move at the beginning of this month, and then a week and a half long flag. It was up 2.54, or 5%, to 56.40, on 1.8 million shares traded on Wednesday, and looks like it’s going higher upwards to 70, and then 80.

Nektar Therapeutics (NASDAQ:NKTR) has been a fantastic swing trade. It popped out and went like a rocket ship from 25 1/2 to 43. On Wednesday it was up 3.51, or 9%, to 43.07, on nearly 4 million shares traded. It may run up a little further, but it’s long-in-the-tooth, at the top of the channel, and overbought. Near-term targets are 45, and then 48-50, before it pulls back. Secondary target is 58-9. There are 12.7 days to cover .

Nutanix, Inc. (NASDAQ:NTNX) has been backing and filling in a choppy manner in a rising channel for the last 5 weeks. On Wednesday, it jumped 81 cents, or 3%, to 29.11, on 2.2 million shares traded. I think it’s about to breakout. If it gets to 29 1/2, we should see 32, and then 34-5. Almost 5 days to cover .

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

On the long side, stocks included Abeona Therapeutics Inc. (NASDAQ:ABEO), Concert Pharmaceuticals, Inc. (NASDAQ:CNCE), Collegium Pharmaceutical, Inc. (COLL), Dicerna Pharmaceuticals, Inc. (NASDAQ:DRNA), Immunomedics, Inc. (NASDAQ:IMMU), Juno Therapeutics, Inc. (JUNO), Mirati Therapeutics, Inc. (NASDAQ:MRTX), Nektar Therapeutics (NASDAQ:NKTR), Nutanix, Inc. (NASDAQ:NTNX), The Children's Place, Inc. (NASDAQ:PLCE), Riot Blockchain, Inc. (NASDAQ:RIOT), Roku, Inc. (NASDAQ:ROKU), Sangamo Therapeutics, Inc. (NASDAQ:SGMO), Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI), Westport Fuel Systems Inc. (NASDAQ:WPRT), and YY Inc. (NASDAQ:YY).

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.